Cite
HARVARD Citation
Williams, L. et al. (n.d.). An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A‐4 3‐O‐phosphate. British journal of pharmacology. pp. 4902-4913. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Williams, L. et al. (n.d.). An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A‐4 3‐O‐phosphate. British journal of pharmacology. pp. 4902-4913. [Online].